Research - , California, United States
Anaphore is pioneering Atrimer™ therapeutics —a new class of protein pharmaceuticals that promise to surpass the therapeutic reach of today's biologics. The company uses its proprietary Atrimer technology platform to rapidly identify and program trivalent proteins that can block or activate virtually any target in disease pathways. Though focusing on oncology and immunology, Anaphore is committed to collaborating with partners across the spectrum of therapeutic indications.